Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets-Tan R, Guren MG, Hospers GAP, Lonardi S, Nagtegaal ID, Perez RO, Cervantes A, Martinelli E, ESMO Guidelines Committee (2025)
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Ann Oncol (in press)
DOI 10.1016/j.annonc.2025.05.528, PubMed 40412553

Sorbye H, Hjortland GO, Vestermark LW, Ladekarl M, Svensson J, Sundlöv A, Janson ET, Garresori H, Hofsli E, Kersten C, Elvebakken H, Pfeiffer P, Morken S, Assmus J, Lothe IMB, Tabaksblat E, Knigge U, Couvelard A, Perren A, Langer SW (2025)
Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
Br J Cancer (in press)
DOI 10.1038/s41416-025-03054-w, PubMed 40382522

Sodergren SC, Edwards R, Krishnatry R, Guren MG, Dennis K, Franco P, de Felice F, Darlington AS, Vassiliou V (2025)
Improving our understanding of the quality of life of patients with metastatic or recurrent/persistent anal cancer: a systematic review
Support Care Cancer, 33 (6), 475
DOI 10.1007/s00520-025-09520-8, PubMed 40372578